We spoke to Professor Hugh Calkins (Nicholas J. Fortuin M.D. Professor of Cardiology, Director, Electrophysiology Laboratory and Arrhythmia Service, Johns Hopkins Hospital, Baltimore, MD, USA) at Heart Rhythm 2019 about upcoming developments in atrial fibrillation (AF) ablation and his thoughts on the use or the discontinuation of anticoagulants in patients without recurrence after AF ablation.
Filmed at Heart Rhythm 2019, San Francisco, CA, USA.
Speaker’s Disclosures: Hugh Calkins is a consultant for and has received honoraria from Biosense Webster, Medtronic, Abbott, Boston Scientific and Boehringer Ingelheim.
1. What developments should we expect to see in atrial fibrillation (AF) ablation over the next few years? (0:09)
2. What are your thoughts on the use versus the discontinuation of anticoagulants in patients without recurrence of disease after AF ablation? (0:53)
3. What are your key take-home messages from Heart Rhythm 2019? (2:02)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Atrial Fibrillation
Ole De Backer, TCT 2022: FEops HEARTguide™ Computational Modelling for left atrial appendage (LAA) closure, the PREDICT LAA trial
The PREDICT LAA trial aimed to examine whether cardiac computed tomography- based FEops HEARTguide™ computational modelling would benefit clinical outcomes when planning for left atrial appendage (LAA) closure. In this touchCARDIO interview, we speak with Dr Ole De Backer (Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark) to discuss the PREDICT LAA trial and the next steps. […]
Ole De Backer, TCT 2022: The use of cardiac computed tomography-based patient-specific computational simulations in left atrial appendage (LAA) closure
When performing percutaneous left atrial appendage (LAA) closure, challenges arise that impact clinical outcomes and cardiac computed tomography (CCT)- based patient-specific computational simulations provide device-host interactions. In this touchCARDIO interview, we speak with Dr Ole De Backer (Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark) to discuss these challenges and the use of cardiac computed tomography (CCT)- […]
Hugh Calkins: What can we look forward to at the Heart Rhythm Congress 2022
Prof Hugh Calkins (The Johns Hopkins University School of Medicine, Baltimore, Md, USA) explains how the Arrhythmia Alliance has been instrumental in empowering patients to become advocates for themselves, ask more questions and increase their knowledge. The Heart Rhythm Congress 2022 is back in person and a unique chance to bring patients and healthcare professionals […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!